首页> 外文期刊>Journal of Diabetes and Endocrinology >Anti-diabetic and some haematological effects of ethylacetate and n-butanol fractions of Indigofera pulchra extract on alloxan-induced diabetic Wistar rats
【24h】

Anti-diabetic and some haematological effects of ethylacetate and n-butanol fractions of Indigofera pulchra extract on alloxan-induced diabetic Wistar rats

机译:靛蓝提取物的乙酸乙酯和正丁醇馏分对四氧嘧啶致糖尿病的Wistar大鼠的抗糖尿病作用和某些血液学作用

获取原文
           

摘要

The current orthodox treatment modalities for diabetes mellitus have many drawbacks including undesirable side-effects and the high cost of long-term treatment. The aim of this study is to determine the anti-diabetic and some haematological effects of ethylacetate and n-butanol fractions of?Indigofera?pulchraextract in alloxan-induced diabetic. Preliminary phytochemical screening and acute toxicity studies of the two fractions of?I.?pulchra?were carried out. A dose of 50 mg/kg of ethylacetate and 250 mg/kg n-butanol fractions of the extract was given intraperitoneally daily, for two weeks to the alloxan-induced diabetic Wistar rats. Insulin was also used as a standard anti-diabetic drug and was given intraperitoneally to alloxan-induced diabetic Wistar rats. The fasting blood glucose levels were determined weekly for two weeks. At the end of the two weeks, the animals were sacrificed and blood samples were taken from all the groups for the determination of hematological parameters. The preliminary phytochemical screening of the two fractions?I.?pulchra?extract revealed the presence of alkaloids, flavonoids, and saponins. The LD50?was 775 and 2,154 mg/kg for ethylacetate and n-butanol fractions of the?I.?pulchra?extract respectively. There was a significant (p<0.05) reduction in the fasting blood glucose levels of the alloxan-induced diabetic groups after 1 and 2 weeks of treatment with ethylacetate fraction. As regard to the n-butanol, there was a significant (p<0.05) reduction in the fasting blood glucose levels of the alloxan-induced diabetic groups after 2 weeks of treatment. Also, in relation to the erythrocyte indices, there was no significant change in the two fractions tested when compared to control. However, there was a significant increase (p<0.05) in the white blood cells, neutrophils and eosinophils counts treated with the two fractions after 2 week of treatment when compared with the control. In conclusion, both ethylacetate and n-butanol fractions of?I.pulchra?extract were found to have potent anti-diabetic effects.
机译:当前用于糖尿病的正统治疗方式具有许多缺点,包括不良的副作用和长期治疗的高成本。这项研究的目的是确定在四氧嘧啶引起的糖尿病中,靛蓝提取物的乙酸乙酯和正丁醇馏分的抗糖尿病作用和某些血液学作用。进行了两部分“ I.pulchra”的初步植物化学筛选和急性毒性研究。每天将腹膜内给予剂量为50 mg / kg乙酸乙酯和250 mg / kg正丁醇级分的提取物,持续2周给四氧嘧啶诱导的糖尿病Wistar大鼠。胰岛素还用作标准的抗糖尿病药物,并腹膜内给予四氧嘧啶诱导的糖尿病Wistar大鼠。每周两次测定空腹血糖水平,持续两周。在两周结束时,处死动物并从所有组中取血样以确定血液学参数。对这两种提取物的初步植物化学筛选显示,存在生物碱,类黄酮和皂苷。 I.pulchraβ提取物的乙酸乙酯和正丁醇馏分的LD50分别为775和2,154 mg / kg。用乙酸乙酯馏分治疗1和2周后,四氧嘧啶诱导的糖尿病组的空腹血糖水平显着降低(p <0.05)。对于正丁醇,治疗2周后,四氧嘧啶诱导的糖尿病组的空腹血糖水平显着降低(p <0.05)。另外,关于红细胞指数,与对照相比,测试的两个部分没有显着变化。但是,与对照组相比,在治疗2周后,用这两种级分治疗的白细胞,嗜中性粒细胞和嗜酸性粒细胞计数显着增加(p <0.05)。总之,发现I.pulchraβ提取物的乙酸乙酯和正丁醇级分均具有有效的抗糖尿病作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号